TVM Capital Technology is a private equity general partner firm headquartered in Munich, Germany.
Bristol-Myers Squibb has acquired F-Star Alpha, a Vienna-based, PE-backed company, for $475m.
F-star Alpha, formed by F-star Biotechnology, raised €9.4m in Series A funding from Atlas Venture, Aescap Venture, TVM Capital among others.
Enanta Pharmaceuticals, backed by Advent International, AlpInvest Partners, among others, announced the pricing of its IPO at $14 per share.
Read more news concerning TVM Capital Technology
A sampling of TVM Capital Technology portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?